Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
Israel's Teva Pharmaceutical Industries will pay $40.5 billion in cash and stock for Allergan's generic drugs business, solidifying Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs, paying down debt and potential "transformational" acquisitions.
Small-business owners are descending on Washington this week to lobby Congress to roll back an ObamaCare rule that could hit companies with thousands of dollars’ worth of penalties.
Republicans and some Democrats in Congress are pressing to repeal the Affordable Care Act’s Cadillac tax—a 40 percent excise tax on high-cost employer-sponsored health insurance plans.
Anthem Inc.’s bid to become the largest health insurer in history is setting up one of the biggest debt offerings backing a takeover.
How much money people have to fork over when they go to the doctor can make a big difference in how satisfied they are with their health plan, a recent study suggests.
Healthcare advocates in California this year successfully pushed for medical coverage for kids who are in the country illegally. But they say they're not satisfied.
UnitedHealth had the opportunity to join Covered California in 2013 as the Affordable Care Act was rolled out. However, the insurer left the state's individual health insurance market and decided not to participate in most of the ACA exchanges across the country.
The price of health care has grown more slowly than core consumer prices—what Americans spend on everything except food and energy—over the past five years. It’s the first time that’s happened since record-keeping started in 1959.
The cost of private individual health plans on California's state-run market will increase about 4 percent for the second straight year, evidence the strategy of forcing insurers to compete is controlling costs, program officials said Monday.
As Medicare approaches its 50th anniversary next week, the federal program got some welcome financial news Wednesday: Its giant hospital trust fund will be solvent until 2030, and its long-term outlook has improved, according to a report from the program’s trustees.